Therapeutic vaccines for breast cancer: Has the time finally come?

The ability to exploit the immune system as a weapon against cancer has revolutionised the treatment of cancer patients, especially through immune checkpoint inhibitors (ICIs). However, ICIs demonstrated a modest benefit in treating breast cancer (BC), with the exception of certain subsets of triple...

Descripción completa

Detalles Bibliográficos
Autores principales: Corti, Chiara, Giachetti, Pier P.M.B., Eggermont, Alexander M.M., Delaloge, Suzette, Curigliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608270/
https://www.ncbi.nlm.nih.gov/pubmed/34823982
http://dx.doi.org/10.1016/j.ejca.2021.10.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608270/
https://www.ncbi.nlm.nih.gov/pubmed/34823982
http://dx.doi.org/10.1016/j.ejca.2021.10.027

Ejemplares similares